Doctor... I Have Rheumatoid Arthritis And I'm Short Of Breath. What's Going On?

Rheumatoid arthritis is a chronic, progressive,identification and treatment may improve
systemic, autoimmune condition for which there isoutcomes."
no known cure. It is a common disorder affectingThe authors recruited 64 patients with
approximately 2.1 million Americans.rheumatoid arthritis without shortness of breath
While it is technically a form of arthritis,or cough and 10 with rheumatoid arthritis and
rheumatoid arthritis is a true systemic disease inpulmonary fibrosis (interstitial lung disease).
which multiple organ systems can be affected.High-resolution computed tomography identified
Among these are the skin with vasculitic ulcers,preclinical interstitial lung disease in 21 of the
eyes leading to scleritis or episcleritisasymptomatic patients (33%).
(inflammatory eye disease), glands that makePulmonary function tests such as air flow and lung
saliva and tears leading to dryness of the eyesvolumes which measure lung function were
and mouth, lymph nodes sometimes causingnormal in the interstitial lung disease patients at
lymphoma, cardiovascular system leading to earlybaseline, but gas exchange (the ability to transfer
heart attack and stroke, and the lungs.oxygen into the lungs and get rid of carbon
Lung involvement can take multiple forms.dioxide out of the lungs) was impaired in patients
Rheumatoid arthritis can cause pleurisywith no interstitial lung disease.
(inflammation of the lining of the lungs), nodulesDuring a mean follow-up of 2 years, repeat
within the lungs, pneumonia, inflammation of thescanning showed disease progression in 12
small airways (bronchitis and bronchiolitis), andsubjects with preclinical interstitial lung disease and
inflammation of the lung tissue. This latterin 6 subjects with pulmonary fibrosis; the rate of
condition is called interstitial lung disease.change was low and similar in the two groups.
Patients with rheumatoid arthritis are examined"In this cohort of patients with rheumatoid
clinically and sometimes interstitial lung disease is aarthritis, preclinical interstitial lung disease is
finding that is picked up on physical examination.prevalent and progressive," the authors stated.
Prior to starting drugs such as TNF inhibitorsThey also wrote: "The natural history of disease
(Enbrel, Humira, Remicade), a chest x-ray is alsoresembles that of pulmonary fibrosis, and high
obtained and sometimes interstitial lung disease isresolution computed tomography is more
found then. However, chest x-ray is not verysensitive than pulmonary function test
sensitive for picking up interstitial lung diseasemeasurements in detecting early progression of
early.preclinical interstitial lung disease."
A recent study found some disturbing evidenceTwo thirds of patients with lung disease and less
that oftentimes patients with rheumatoid arthritisthan one quarter without lung disease had a
may have subclinical interstitial lung disease. Thishistory of smoking, and the mean number of
means that the lung disease is there without anypack-years smoked was significantly higher in the
symptoms.lung disease group. Therefore, the authors say,
The researchers found that "preclinical interstitialclinicians should recommend that patients with
lung disease detected by high-resolution computedrheumatoid arthritis should stop smoking.
tomography is prevalent and progressive inThe scientists concluded: "High resolution
patients with rheumatoid arthritis." (Arch Interncomputed tomography may be indicated to
Med 2008;168:159-166). High resolutionidentify early preclinical ILD in patients with RA
computerized tomography is a fine detail CATwhose physical examinations reveal crackles."
scan technique.Author's note: I agree with these findings and
The prevalence of asymptomatic interstitial lungalways send patients for a CAT scan of the lungs
disease in rheumatoid arthritis is unknown. Theif I detect crackles on physical examination. The
authors of the study said, though, that "given thepresence of lung disease is also a prompt to
availability of new therapeutic options, earlybecome more aggressive with treatment.